特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
921932

世界の能動埋込型医療機器市場:成長、動向、および予測

Active Implantable Medical Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

出版日: | 発行: Mordor Intelligence LLP | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.40円
世界の能動埋込型医療機器市場:成長、動向、および予測
出版日: 2020年06月01日
発行: Mordor Intelligence LLP
ページ情報: 英文 111 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界の能動埋込型医療機器市場について調査しており、市場機会や動向、成長および阻害要因、製品・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 心血管疾患・神経疾患の増加する負担
    • 技術的に高度な製品を開発するための投資と資金
  • 市場阻害要因
    • 埋込型医療機器の使用に関する問題
    • 埋込の高いコストと厳しい規制
  • ポーターのファイブフォース分析

第5章 市場セグメンテーション

  • 製品別
    • 埋込型除細動器
    • 埋込型心臓ペースメーカー
    • 心室補助装置
    • 埋込型心臓モニター/埋込型ループレコーダー
    • 神経刺激装置
    • 埋込型補聴器
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Abbott Laboratories
    • Biotronik Se & Co., Kg
    • Boston Scientific Corporation
    • Cochlear Limited
    • Livanova PLC
    • Med-EL
    • Medtronic PLC
    • Nurotron Biotechnology Co. Ltd.
    • William Demant Holding A/S

第7章 市場機会および今後の動向

目次
Product Code: 67244

Global Active Implantable Medical Devices market is expected to witness a CAGR of 7.2% during the forecast period. Certain factors that are driving the market growth include increasing burden of cardiovascular and neurological diseases and investments and funds to develop technologically advanced products.

Increasing geriatric population is one of the important drivers propelling the growth of the market. The number of people aged 65 or older is projected to increase from 524 million in 2010, to nearly 1.5 billion in 2050, representing about 16% of the world's population. Furthermore, increasing chronic diseases coupled with the advancements in the active implantable medical devices are projected to boost the market growth. However, rising demand for non-invasive procedures, issues related to implantable devices and high cost of the devices anticipated to impede the market growth.

Key Market Trends

Implantable Cardiac Pacemaker is Expected to Witness Healthy Growth Over the Forecast Period

The implantable pacemakers are of three major types, namely, single-chamber, dual-chamber, and biventricular pacemakers. The growth of the segment can be attributed to factors, such as reduced post-surgical complications and the presence of multiple leads in order to assure normal physiology of the heart.

According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds. Coronary heart disease (CHD) accounts for the majority of CVD deaths, followed by stroke and heart failure. According to the European Heart Network, every year, cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union (EU). The implantable pacemaker segment is growing rapidly, due to increasing R&D funding for healthcare and increasing R&D trends in emerging economies.

North America Dominates the Market and Expected to do Same in the Forecast Period

The rising prevalence of cardiovascular diseases, high obesity rates, and favorable reimbursement environments are the primary factors which are driving the market growth. According to American Heart Association (AHA) estimates about 5.7 million adults in the United States are suffering from congestive heart failure. And about one in nine deaths include heart failure as contributing cause. As per Centers for Disease Control and Prevention (CDC) statistics, more than three million people in the United States suffer from atrial fibrillation, which is the most common type of abnormal heart rhythm. Furthermore, the number is expected to quadruple by 2050, as the population ages.

Furthermore, in the region, several trails are being conducted on different types of hearing aids. Hospital and medical centres, along with research institutes, collaborated with companies across the world. Nearly 15% of the population is above 65 years, who primarily require these devices.

Competitive Landscape

The global Active Implantable Medical Devices market is moderately competitive and consists of a few major players.

In November 2017, Medtronic PLC has announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure pacemakers with BlueSync technology. Available in both single chamber and dual chamber models, the Azure XT MRI and Azure S MRI pacemakers offer improved longevity, estimated at 13.7 years (dual chamber) or 27 percent longer than its previous version.

Companies like Abbott Laboratories, Biotronik Se & Co., Kg, Boston Scientific Corporation, Cochlear Limited, Livanova PLC, Med-EL, Medtronic PLC, Nurotron Biotechnology Co. Ltd., William Demant Holding A/S, among others, hold the substantial market share in the Active Implantable Medical Devices market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Cardiovascular and Neurological Diseases
    • 4.2.2 Investments and Funds to Develop Technologically Advanced Products
  • 4.3 Market Restraints
    • 4.3.1 Issues Related to the Use of Implantable Medical Devices
    • 4.3.2 High Cost of Implants and Stringent Regulations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Implantable Cardioverter Defibrillators
    • 5.1.2 Implantable Cardiac Pacemakers
    • 5.1.3 Ventricular Assist Devices
    • 5.1.4 Implantable Heart Monitors/Insertable Loop Recorders
    • 5.1.5 Neurostimulators
    • 5.1.6 Implantable Hearing Devices
    • 5.1.7 Others
  • 5.2 Geography
    • 5.2.1 North America
      • 5.2.1.1 United States
      • 5.2.1.2 Canada
      • 5.2.1.3 Mexico
    • 5.2.2 Europe
      • 5.2.2.1 Germany
      • 5.2.2.2 United Kingdom
      • 5.2.2.3 France
      • 5.2.2.4 Italy
      • 5.2.2.5 Spain
      • 5.2.2.6 Rest of Europe
    • 5.2.3 Asia-Pacific
      • 5.2.3.1 China
      • 5.2.3.2 Japan
      • 5.2.3.3 India
      • 5.2.3.4 Australia
      • 5.2.3.5 South Korea
      • 5.2.3.6 Rest of Asia-Pacific
    • 5.2.4 Middle-East and Africa
      • 5.2.4.1 GCC
      • 5.2.4.2 South Africa
      • 5.2.4.3 Rest of Middle-East and Africa
    • 5.2.5 South America
      • 5.2.5.1 Brazil
      • 5.2.5.2 Argentina
      • 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Biotronik Se & Co., Kg
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Cochlear Limited
    • 6.1.5 Livanova PLC
    • 6.1.6 Med-EL
    • 6.1.7 Medtronic PLC
    • 6.1.8 Nurotron Biotechnology Co. Ltd.
    • 6.1.9 William Demant Holding A/S

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.